Plasma cell leukemia: from biology to treatment

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61988987%3A17110%2F15%3AA1601FXJ" target="_blank" >RIV/61988987:17110/15:A1601FXJ - isvavai.cz</a>

Alternative codes found

RIV/00843989:_____/15:E0104731

Result on the web

—

DOI - Digital Object Identifier

—

Result language

angličtina

Original language name

Plasma cell leukemia: from biology to treatment

Original language description

Plasma cell leukemia (PCL) is a very aggressive and rare form of malignant monoclonal gammopathy characterized by the presence of plasmocytes in peripheral blood. It is classified as primary PCL occuring de novo', or as secondary PCL in patients with relapsed/refractory multiple myeloma. Primary PCL is a distinct clinicopathological entity from myeloma with different cytogenetic abnormalities and molecular findings, which are usually found only in advanced multiple myeloma. The clinical course is aggressive with short remissions and reduced overall survival. The diagnostic criteria are based on the percentage (>20%) and absolute number (2x10(9)/L) of plasma cells in peripheral blood.

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FD - Oncology and haematology

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

EUR J HAEMATOL

ISSN

0902-4441

e-ISSN

—

Volume of the periodical

95

Issue of the periodical within the volume

1

Country of publishing house

US - UNITED STATES

Number of pages

11

Pages from-to

16-26

UT code for WoS article

000356676600003

EID of the result in the Scopus database

—